The generic-patent medicine conflict flares up again in The Netherlands.
Gebhardt
D O E
DO
D004345:Drug Industry; D016568:Drugs, Generic / Q000191:economics / Q000627:therapeutic use*; D005194:Family Practice / Q000191:economics / Q000941:ethics; D006801:Humans; D007343:Insurance Carriers / Q000191:economics / Q000941:ethics; D007348:Insurance, Health / Q000941:ethics; D009042:Motivation; D009426:Netherlands
D016568:Drugs, Generic